MARGARET HUGHES: Open Payments
NPI 1184142820 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,535 in 131 payments from 11 companies in 2025. Trend: 2023 $1,301 · 2024 $1,564 · 2025 $2,535
Food & beverage: $2,453Education: $82
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 17 | $542 |
| Neurocrine BioSciences, Inc. | 18 | $401 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $391 |
| Otsuka America Pharmaceutical, Inc. | 18 | $225 |
| Vanda Pharmaceuticals Inc. | 13 | $219 |
| Axsome Therapeutics, Inc. | 9 | $210 |
| Janssen Pharmaceuticals, Inc | 10 | $180 |
| E.R. Squibb & Sons, L.L.C. | 9 | $166 |
| Alkermes, Inc. | 4 | $83 |
| ABBVIE INC. | 4 | $76 |
Products named: UZEDY, INGREZZA, CAPLYTA, FANAPT, Auvelity, REXULTI, COBENFY, INVEGA SUSTENNA.
Industry payments across LA — which companies pay providers there.
